Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Palve, Vinayak C ^a   Teni, Tanuja R ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN MCL 1;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CLONOGENIC ASSAY; DOWN REGULATION; IMMUNOFLUORESCENCE; IONIZING RADIATION; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL; WESTERN BLOTTING;

ALTERNATIVE SPLICING; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; COBALT RADIOISOTOPES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MOUTH NEOPLASMS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RADIATION, IONIZING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84864550534     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-135     Document Type: Article

References (33)

1. Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 2001, 84:739-742. 10.1054/bjoc.2000.1674, 2363816, 11259085.
2. Burri RJ, Lee NY. Concurrent chemotherapy and radiotherapy for head and neck cancer. Expert Rev Anticancer Ther 2009, 9:293-302. 10.1586/14737140.9.3.293, 19275508.
3. Mathew Iype E, Pandey M, Mathew A, Thomas G, Krishnan Nair M. Squamous cell cancer of the buccal mucosa in young adults. Br J Oral Maxillofac Surg 2004, 42:185-189.
4. Kyprianou N, King E, Bradbury D, Rhee J. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer 1997, 70:341-348. 10.1002/(SICI)1097-0215(19970127)70:3<341::AID-IJC16>3.0.CO;2-I, 9033638.
5. Wang ZB, Zhang Y, Liu YQ, Guo Y, Xu H, Dong B, Cui YF. Bcl-xL overexpression restricts gamma-radiation-induced apoptosis. Cell Biol Int 2006, 30:15-20. 10.1016/j.cellbi.2005.08.006, 16253528.
6. Craig R. MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 2002, 16:444-454. 10.1038/sj.leu.2402416, 11960321.
7. Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia BP, Peck-Radosavljevic M, Wacheck V. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J Hepatol 2006, 44:151-157. 10.1016/j.jhep.2005.09.010, 16289418.
8. Derenne S, Monia B, Dean N, Taylor J, Rapp M, Harousseau J, Bataille R, Amiot M. Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells. Blood 2002, 100:194. 10.1182/blood.V100.1.194, 12070027.
9. Cho-Vega JH, Rassidakis GZ, Admirand JH, Oyarzo M, Ramalingam P, Paraguya A, McDonnell TJ, Amin HM, Medeiros LJ. MCL-1 expression in B-cell non-Hodgkin's lymphomas. Hum Pathol 2004, 35:1095-1100. 10.1016/j.humpath.2004.04.018, 15343511.
10. Mallick S, Patil R, Gyanchandani R, Pawar S, Palve V, Kannan S, Pathak KA, Choudhary M, Teni TR. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1. J Pathol 2009, 217:398-407. 10.1002/path.2459, 19009587.
11. Mallick S, Agarwal J, Kannan S, Pawar S, Kane S, Teni T. PCNA and anti-apoptotic Mcl-1 proteins predict disease-free survival in oral cancer patients treated with definitive radiotherapy. Oral Oncol 2010, 46:688-693. 10.1016/j.oraloncology.2010.04.003, 20729132.
12. Guoan X, Hanning W, Kaiyun C, Hao L. Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo. Surgery 2010, 147:553-561. 10.1016/j.surg.2009.10.033, 20004446.
13. Skvara H, Thallinger C, Wacheck V, Monia BP, Pehamberger H, Jansen B, Selzer E. Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death. Anticancer Res 2005, 25:2697-2703.
14. Kim JH, Sim SH, Ha HJ, Ko JJ, Lee K, Bae J. MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death. FEBS Lett 2009, 583:2758-2764. 10.1016/j.febslet.2009.08.006, 19683529.
15. Tatake RJ, Rajaram N, Damle RN, Balsara B, Bhisey AN, Gangal SG. Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors. J Cancer Res Clin Oncol 1990, 116:179-186. 10.1007/BF01612674, 1691185.
16. Raul U, Sawant S, Dange P, Kalraiya R, Ingle A, Vaidya M. Implications of cytokeratin 8/18 filament formation in stratified epithelial cells: induction of transformed phenotype. Int J Cancer 2004, 111:662-668. 10.1002/ijc.20349, 15252834.
17. Franken N, Rodermond H, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006, 1:2315-2319. 10.1038/nprot.2006.339, 17406473.
18. Fukuda K, Sakakura C, Miyagawa K, Kuriu Y, Kin S, Nakase Y, Hagiwara A, Mitsufuji S, Okazaki Y, Hayashizaki Y, Yamagishi H. Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 2004, 91:1543-1550. 10.1038/sj.bjc.6602187, 2409931, 15365572.
19. Opferman JT. Unraveling MCL-1 degradation. Cell Death Differ 2006, 13:1260-1262. 10.1038/sj.cdd.4401978, 16710358.
20. Mott JL, Kobayashi S, Bronk SF, Gores GJ. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26:6133-6140. 10.1038/sj.onc.1210436, 2432524, 17404574.
21. Warr MR, Acoca S, Liu Z, Germain M, Watson M, Blanchette M, Wing SS, Shore GC. BH3-ligand regulates access of MCL-1 to its E3 ligase. FEBS Lett 2005, 579:5603-5608. 10.1016/j.febslet.2005.09.028, 16213503.
22. Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F, Wang X. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003, 17:1475. 10.1101/gad.1093903, 196078, 12783855.
23. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006, 21:749-760. 10.1016/j.molcel.2006.02.009, 16543145.
24. Bae J, Leo CP, Hsu SY, Hsueh AJ. MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem 2000, 275:25255-25261. 10.1074/jbc.M909826199, 10837489.
25. Thomas LW, Lam C, Edwards SW. Mcl-1; the molecular regulation of protein function. FEBS Lett 2010, 584:2981-2989. 10.1016/j.febslet.2010.05.061, 20540941.
26. Wacheck V, Selzer E, Gunsberg P, Lucas T, Meyer H, Thallinger C, Monia BP, Jansen B. Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells. Br J Cancer 2003, 89:1352-1357. 10.1038/sj.bjc.6601254, 2394316, 14520471.
27. Zhao J, Xin M, Wang T, Zhang Y, Deng X. Nicotine enhances the antiapoptotic function of Mcl-1 through phosphorylation. Mol Cancer Res 2009, 7:1954-1961. 10.1158/1541-7786.MCR-09-0304, 2796280, 19903766.
28. Leuenroth SJ, Grutkoski PS, Ayala A, Simms HH. The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis. J Leukoc Biol 2000, 68:158.
29. Jamil S, Sobouti R, Hojabrpour P, Raj M, Kast J, Duronio V. A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1. Biochem J 2005, 387:659. 10.1042/BJ20041596, 1134995, 15554878.
30. Yang-Yen HF. Mcl-1: a highly regulated cell death and survival controller. J Biomed Sci 2006, 13:201-204. 10.1007/s11373-005-9064-4, 16456709.
31. Cuconati A, Mukherjee C, Perez D, White E. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev 2003, 17:2922-2932. 10.1101/gad.1156903, 289151, 14633975.
32. Pawlikowska P, Leray I, de Laval B, Guihard S, Kumar R, Rosselli F, Porteu F. ATM-dependent expression of IEX-1 controls nuclear accumulation of Mcl-1 and the DNA damage response. Cell Death Differ 2010, 17:1739-1750. 10.1038/cdd.2010.56, 20467439.
33. Paik PK, Rudin CM, Pietanza MC, Brown A, Rizvi NA, Takebe N, Travis W, James L, Ginsberg MS, Juergens R. A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer 2011, 74-481. Lung cancer, Amsterdam, Netherlands.